European Movers: Croda (CRDA LN) +2.0%, Endesa (ELE SM) +4.1%, Edenred (EDEN FP) +5.2%, Convatec (CTEC LN) +9.2%, Novo Nordisk (NOVOB DC) -3.5%, Unite (UTG LN) -7.1%, Fresenius Medical Care (FME GY) -9.8%

Croda (CRDA LN) - FY 2025 (GBP): Revenue 1.70bln (prev. 1.63bln Y/Y), EBITDA 396mln (prev. 378mln Y/Y); expects sales in Q1 to be similar to the prior year at constant currency. (Croda)  

Endesa (ELE SM) - FY 2025 (EUR): Revenue 21.42bln (prev. 21.31bln Y/Y), EBITDA 5.76bln (exp. 5.60bln), Net income 2.2bln (exp. 2.13bln).  (Endesa) 

Edenred (EDEN FP) - FY 2025 (EUR): Revenue 2.96bln (exp. 2.95bln), EBITDA 1.36bln (exp. 1.34bln), Net Income 521mln (exp. 508mln). (Edenred)

Convatec (CTEC LN) - FY 2025 (USD): Revenue 2.44bln (exp. 2.43bln), adj. EBIT 316mln (exp. 525mln), adj. 0.086 (prev. 0.093 Y/Y). (Convatec)   

Novo Nordisk (NOVOB DC) downgraded to Hold from Buy at Kepler Cheuvreux; PT cut to DKK 280/shr (prev. DKK 400/shr)

Unite (UTG LN) - Q1 2025 (GBP): EPS 47.5p (prev. 46.6p Y/Y), Adj. Earnings 232.3mln (prev. 213.8mln Y/Y). Announced the disposal of GBP 186mln assets to USAF. 2026 Guidance: 2026/27 income expected at lower end of range for 2-3% rental growth and 93-96% occupancy  (Unite)

Fresenius Medical Care (FME GY) - Q4 2025 (EUR): Revenue 5.07bln (exp. 5.03bln, prev. 5.09bln Y/Y), Adj. Operating Income 705mln (prev. 589mln Y/Y), Adj. Op. Profit 594mln (exp. 565mln), EPS 1.44 (prev. 0.9 Y/Y). Declares dividend of EUR 1.49/shr (prev. EUR 1.44/shr). Expects rev. growth to be broadly flat in 2026. Sees 2026 Op. Profit Before Special Items on Consistent Level. (Fresenius Medical Care)